-

12:51:05 PM

ICLR Stock News

ICLR - Icon Plc

09/21/23 6:00 AM

Nasdaq : ICLR

earnings

ICON plc Schedules Third Quarter 2023 Earnings Conference Call

ICON plc, a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2023 after the market closes on Wednesday, October 25, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 26, 2023...

RHEA-AI

neutral

09/20/23 7:15 AM

Nasdaq : ICLR

clinical trial

ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution

ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’ s proprietary tokenisation engine, access to real-world data and advanced clinical analytics expertise, now delivered through a cohesive and seamless...

RHEA-AI

positive

09/13/23 7:15 AM

Nasdaq : ICLR

partnershipclinical trialcovid-19

BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial

ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to...

RHEA-AI

neutral

09/06/23 6:00 AM

Nasdaq : ICLR

conferences

ICON plc to Present at the Baird Global Healthcare Conference

ICON plc, a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird Global Healthcare Conference on Wednesday, September 13, 2023 at 10:15 am ET. With headquarters in Dublin, Ireland, ICON employed approximately 41,160 employees in 108 locations in 53...

RHEA-AI

neutral

07/26/23 4:20 PM

Nasdaq : ICLR

ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting

ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced that all resolutions at the Annual General Meeting of the Company held on July 25, 2023 were all duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 12, 2023 and are available on the ICON plc...

RHEA-AI

neutral

07/26/23 4:15 PM

Nasdaq : ICLR

earnings

ICON Reports Second Quarter 2023 Results

We now expect revenue in the range of $8,070- $8,210 million for the full-year 2023, representing growth of 4.3 to 6.1% on a year over year basis. Given our strong margin performance, as well as a more favorable tax position, we are revising our adjusted earnings per share* range to $12.63- $12.91, reflecting a year over year increase of 7.5 to 9.9%, an increase of$. 04 at...

RHEA-AI

neutral

07/13/23 7:15 AM

Nasdaq : ICLR

First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services

ICON plc, a world-leading healthcare intelligence and clinical research organisation, has received positive recognition from leading business and industry organisations as a leading CRO of choice and a top-rated employer in the first half of 2023.. For its excellent performance in clinical research, ICON was named a recipient of the 2023 CRO Leadership...

RHEA-AI

very positive

06/27/23 4:15 PM

Nasdaq : ICLR

earnings

ICON plc Schedules Second Quarter 2023 Earnings Conference Call

ICON plc, a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2023 after the market closes on Wednesday, July 26, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 27, 2023 at...

RHEA-AI

neutral

06/26/23 7:15 AM

Nasdaq : ICLR

ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform

ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform. The platform supports seamless integration of ICON patient, site and sponsor services with the delivery of harmonised data and can be customised for any study design, from traditional to fully decentralised,...

RHEA-AI

positive

06/26/23 6:00 AM

Nasdaq : ICLR

ICON plc Set to Join Russell 3000® Index

ICON plc,, is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today, Monday, June 26.. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization, including both the Russell 3000...

RHEA-AI

neutral

1 2 3 4 5 6 7 Next

ICLR Data

IndustryResearch and Development in Biotechnology
Websitehttp://www.iconplc.com/
Security nameIcon Plc
SectorProfessional, Scientific, and Technical Services
Tags
- Health Technology
- Pharmaceuticals: Other
CountryIreland

About Icon Plc

icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. we specialise in the strategic development, management and analysis of programmes that support clinical development - from compound selection to phase i-iv clinical studies. in a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. we have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. we are also an 'end-to-end' pharmacovigilance service provider and this includes post marketing surveillance activities too.